Source Code LLC Jobs in New Gloucester, ME
Project Management & Strategic Operations Director, Disease Strategy Team (DST) Program Office
Vertex Pharmaceuticals Incorporated - Auburn,ME
Job Description General Summary: Vertex is seeking a talented strategic colleague to serve in a critical role supporting the Disease Strategy Team Program Office in the Office of the CEO. The Strategy & Operations...
Finance Director, US Commercial Pain BU (Hybrid)
Vertex Pharmaceuticals Incorporated - Auburn,ME
Job Description Finance Director, US Commercial Pain BU Job Posting Description Vertex is growing at a rapid pace with invigorating opportunities for motivated professionals who are keen to contribute to the...
Director, Global Value & Access Strategy, povetacicept
Vertex Pharmaceuticals Incorporated - Auburn,ME
Job Description Director, Global Value Access & Strategy, povetacicept Location: Boston, MA (3 days onsite, 2 days remote weekly) Vertex operates at the forefront of scientific innovation and has successfully...
Associate Director, Business engagement and Technology, Medical & External Affairs
Vertex Pharmaceuticals Incorporated - Auburn,ME
Job Description General/Position Summary Vertex is seeking an experienced technology leader to lead the strategy, planning, and delivery to support the Medical Affairs business function across all...
Marketing, Associate Director - Congress Lead
Vertex Pharmaceuticals Incorporated - Auburn,ME
Job Description General Summary: The HCP Marketing Associate Director , Congress Lead is responsible for leading the strategy and execution of...
Marketing, Senior Manager - Speaker Bureau
Vertex Pharmaceuticals Incorporated - Auburn,ME
Job Description General Summary: The HCP Marketing Senior Manager, Speaker Program works within the HCP Marketing team for Vertex's U.S. Commercial Pain Business Unit. They report to the Senior Director, HCP...
Senior Director, Head of Marketing, US Kidney - Pove
Vertex Pharmaceuticals Incorporated - Auburn,ME
Job Description Vertex is seeking a talented leader to join our US Kidney Business Unit to support our aspirations of bringing Povetacicept, a Phase 3 investigational therapy with the potential to transform lives across multiple...